Model for end-stage liver disease (MELD) score and cost-effectiveness on living donor liver transplantation

被引:1
|
作者
Ichida, Takafumi [1 ]
Narita, Yutaka [1 ]
Murakami, Romi [1 ]
机构
[1] Juntendo Univ, Sch Med, Shizuoka Hosp, Dept Gastroenterol & Hepatol, Izunokuni 4102295, Japan
关键词
D O I
10.1007/s00535-006-1959-y
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1023 / 1024
页数:2
相关论文
共 50 条
  • [1] Model for end-stage liver disease (MELD) score and cost-effectiveness on living donor liver transplantation
    Takafumi Ichida
    Yutaka Narita
    Romi Murakami
    Journal of Gastroenterology, 2006, 41 : 1023 - 1024
  • [2] Living donor liver transplantation in high model for end-stage liver disease score
    Dayangac, Murat
    Akyildiz, Murat
    Erdogan, Yalcin
    Gungor, Gokhan
    Tokat, Yaman
    HEPATOLOGY, 2014, 60 : 509A - 510A
  • [3] LIVING DONOR LIVER TRANSPLANTATION IN HIGH MODEL FOR END-STAGE LIVER DISEASE SCORE
    Dayangac, M.
    Akyildiz, M.
    Gungor, G.
    Erdogan, Y.
    Tokat, Y.
    TRANSPLANT INTERNATIONAL, 2014, 27 : 22 - 23
  • [4] Living donor liver transplantation in high Model for End-Stage Liver Disease score patients
    Feng, Sandy
    LIVER TRANSPLANTATION, 2017, 23 : S9 - S21
  • [5] THE IMPACT OF LISTING MODEL FOR END-STAGE LIVER DISEASE (MELD) SCORE ON LIVER TRANSPLANTATION
    Fox, Alyson N.
    Reddy, Rajender
    Guttenberg, Katie B.
    Forde, Kimberly A.
    Ellenberg, Susan
    Lewis, James D.
    HEPATOLOGY, 2010, 52 (04) : 664A - 664A
  • [6] Impact of the Model for End-Stage Liver Disease (MELD) Score on Liver Transplantation in Greece
    Karapanagiotou, A.
    Kydona, C.
    Dimitriadis, C.
    Papadopoulos, S.
    Theodoridou, T.
    Tholioti, T.
    Fouzas, G.
    Imvrios, G.
    Gritsi-Gerogianni, N.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (09) : 3212 - 3215
  • [7] Could tenofovir modify the model end-stage liver disease (MELD) score in patients with end-stage liver disease eligible for liver transplantation?
    Bruno, Raffaele
    Sacchi, Paolo
    Filice, Gaetano
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (01) : 123 - 123
  • [8] Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list
    Ferraz-Neto, B. -H.
    Hidalgo, R.
    Thome, T.
    Melo, V. A., Jr.
    Lobue, A.
    Zurstrassen, M. P. V. C.
    Moraes, J. M., Jr.
    Meira-Filho, S. P.
    Rezende, M. B.
    Fonseca, L. E. P.
    Pandullo, F. L.
    Soeiro, F. S.
    Afonso, R. C.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (08) : 2511 - 2513
  • [9] MELD (model for end-stage liver disease) score does not predict patient or graft survival after living donor liver transplantation.
    Trotter, JF
    Bak, T
    Wachs, M
    Kugelmas, M
    Everson, GT
    Kam, I
    HEPATOLOGY, 2002, 36 (04) : 306A - 306A
  • [10] Utilization of and Outcomes Following Living Donor Liver Transplantation for Recipients with High Model for End-Stage Liver Disease (MELD) Score in the United States
    Kumar, S.
    Lin, S.
    Schold, J. D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S722 - S722